Lunit Inc is a medical software manufacturer specializing in AI software for precision oncology products and tuberculosis detection. The company has developed Immune Phenotyping as a predictive biomarker and is deeply invested in healthcare information security. Their AI software is available in over 56 countries with CE mark, FDA clearance, and MFDS approval.

Headquarters
4F 374Gangnam-Daero, Gangnam-Gu
Seoul; Seoul;

Contact Details: Purchase the Lunit Inc. (Seoul) report to view the information.

Website: http://www.lunit.io

Basic Information

Total Employees:

Purchase the Lunit Inc. (Seoul) report to view the information.

Outstanding Shares:

Purchase the Lunit Inc. (Seoul) report to view the information.

Registered Capital:

Purchase the Lunit Inc. (Seoul) report to view the information.

Financial Auditors:

Purchase the Lunit Inc. (Seoul) report to view the information.

Incorporation Date:

August 27, 2013

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Subsidiaries

Lunit China Co., Ltd.

Lunit Usa, Inc.

Company Performance

Financial values in the chart are available after Lunit Inc. (Seoul) report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

65.94%▲

Total Operating Revenue

66.2%▲

Operating Profit

-28.66%▼

EBITDA

-26.85%▼

Net Profit/Loss for the Period

-66.28%▼

Total Assets

-9.48%▼

Total Equity

-29.33%▼

Operating Profit Margin

32.37%▲

Net Profit Margin

-0.06%▼

Return on Equity (ROE)

-5.21%▼

Debt / Equity

34.84%▲

Quick Ratio

-0.29%▼

Cash Ratio

-0.09%▼

Lunit Inc. (Seoul) (South Korea)

Similar companies